BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23735917)

  • 1. Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?
    Nervi F; Arrese M
    Am J Gastroenterol; 2013 Jun; 108(6):959-61. PubMed ID: 23735917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.
    Ruhl CE; Everhart JE
    Am J Gastroenterol; 2013 Jun; 108(6):952-8. PubMed ID: 23545713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey.
    Yue W; Sun X; Du T
    BMC Endocr Disord; 2019 Sep; 19(1):95. PubMed ID: 31477078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship.
    Arrese M; Cortés V; Barrera F; Nervi F
    Curr Opin Gastroenterol; 2018 Mar; 34(2):90-96. PubMed ID: 29266009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population.
    Kichloo A; Solanki S; Haq KF; Dahiya D; Bailey B; Solanki D; Singh J; Albosta M; Wani F; Aljadah M; Shah H; Khan H; Jafri SM
    World J Gastrointest Pathophysiol; 2021 Mar; 12(2):14-24. PubMed ID: 33815863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study.
    Lu Y; Hu L; Song J; Wan J; Chen H; Yin J
    BMC Endocr Disord; 2021 Nov; 21(1):231. PubMed ID: 34794397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.
    García-Monzón C; Vargas-Castrillón J; Porrero JL; Alonso MT; Bonachía O; Castillo MJ; Marcos A; Quirós E; Ramos B; Sánchez-Cabezudo C; Villar S; Sáez A; Rodríguez de Cía J; del Pozo E; Vega-Piris L; Soto-Fernández S; Lo Iacono O; Miquilena-Colina ME
    Liver Int; 2015 Aug; 35(8):1983-91. PubMed ID: 25708133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
    Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
    Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease.
    Lyu J; Lin Q; Fang Z; Xu Z; Liu Z
    Front Endocrinol (Lausanne); 2022; 13():1032557. PubMed ID: 36506064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome.
    Yener O; Aksoy F; Demır M; Özçelık A; Erengül C
    Turk J Gastroenterol; 2010 Dec; 21(4):411-5. PubMed ID: 21331995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frequency and clinical, biochemical and histological characteristics of nonalcoholic fatty liver disease in patients with gallstone disease].
    Roesch-Dietlen F; Pérez-Morales A; Melo-Santisteban G; Díaz-Blanco F; Martínez-Fernández S; Martínez JA; Cid-Juárez S
    Cir Cir; 2008; 76(1):37-42. PubMed ID: 18492418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
    Stepanova M; Younossi ZM
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?
    Ahmed MH; Ali A
    Scand J Gastroenterol; 2014 May; 49(5):521-7. PubMed ID: 24646400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy.
    Ahmed F; Baloch Q; Memon ZA; Ali I
    Ann Med Surg (Lond); 2017 May; 17():7-13. PubMed ID: 28377802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease].
    Cherkashchenko NA; Livzan MA; Krolevets TS
    Ter Arkh; 2020 Apr; 92(2):48-54. PubMed ID: 32598718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
    Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
    Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development.
    Rodríguez-Antonio I; López-Sánchez GN; Garrido-Camacho VY; Uribe M; Chávez-Tapia NC; Nuño-Lámbarri N
    HPB (Oxford); 2020 Nov; 22(11):1513-1520. PubMed ID: 32773176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study].
    Caballería L; Arteaga I; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P
    Med Clin (Barc); 2013 Sep; 141(6):233-9. PubMed ID: 23601740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Blood Fatty Acid Composition and Dietary Pattern with the Risk of Non-Alcoholic Fatty Liver Disease in Patients Who Underwent Cholecystectomy.
    Shim P; Choi D; Park Y
    Ann Nutr Metab; 2017; 70(4):303-311. PubMed ID: 28595185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.